{"id":455386,"date":"2021-03-10T18:30:17","date_gmt":"2021-03-10T23:30:17","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=455386"},"modified":"2021-03-10T18:30:17","modified_gmt":"2021-03-10T23:30:17","slug":"cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\/","title":{"rendered":"Cipher Pharmaceuticals Schedules Q4 2020 Earnings Release and Conference Call"},"content":{"rendered":"
\n

Canada NewsWire<\/p>\n<\/p><\/div>\n

\n

\n

\n

\n OAKVILLE, ON<\/span>, March 10, 2021<\/span> \/CNW\/ –\u00a0Cipher Pharmaceuticals Inc. (TSX: CPH) (“Cipher<\/b>” or “the Company<\/b>“) today announced it will release its Q4 2020 financial results after the close on Thursday, March 18<\/span>, 2021.\u00a0 The company will hold a conference call on Friday, March 19, 2021<\/span> to discuss the results. \u00a0<\/p>\n

\n CONFERENCE CALL DETAILS<\/b>\n <\/p>\n

\n\n\n\n\n\n\n\n\n
\n

\n DATE:<\/span>\n <\/p>\n<\/td>\n

\n

\n March 19, 2021<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n TIME:<\/span>\n <\/p>\n<\/td>\n

\n

\n 8:30 a.m. EDT<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n DIAL-IN NUMBER:<\/span>\n <\/p>\n<\/td>\n

\n

\n (416) 764-8688 or (888) 390-0546<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n CONFERENCE ID:<\/span>\n <\/p>\n<\/td>\n

\n

\n 92839284<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n REPLAY DIAL-IN:\u00a0<\/span>\n <\/p>\n<\/td>\n

\n

\n (888) 390-0541 (playback 839284 #)<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n \n <\/td>\n\n

\n Expires March 26, 2021<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n WEBCAST:\u00a0<\/span>\n <\/p>\n<\/td>\n

\n

\n
\n https:\/\/produceredition.webcasts.com\/starthere.jsp?ei=1441329&tp_key=f472db2e8d<\/a>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\n About Cipher Pharmaceuticals Inc.
<\/b>Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in\u00a0Canada\u00a0or indirectly through partners in\u00a0Canada, the U.S., and\u00a0South America. For more information, visit\u00a0www.cipherpharma.com<\/a><\/b>.<\/p>\n

SOURCE Cipher Pharmaceuticals Inc.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Canada NewsWire OAKVILLE, ON, March 10, 2021 \/CNW\/ –\u00a0Cipher Pharmaceuticals Inc. (TSX: CPH) (“Cipher” or “the Company“) today announced it will release its Q4 2020 financial results after the close on Thursday, March 18, 2021.\u00a0 The company will hold a conference call on Friday, March 19, 2021 to discuss the results. \u00a0 CONFERENCE CALL DETAILS DATE: March 19, 2021 TIME: 8:30 a.m. EDT DIAL-IN NUMBER: (416) 764-8688 or (888) 390-0546 CONFERENCE ID: 92839284 REPLAY DIAL-IN:\u00a0 (888) 390-0541 (playback 839284 #) Expires March 26, 2021 WEBCAST:\u00a0 https:\/\/produceredition.webcasts.com\/starthere.jsp?ei=1441329&tp_key=f472db2e8d About Cipher Pharmaceuticals Inc.Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages … <\/p>\n

Continue reading “Cipher Pharmaceuticals Schedules Q4 2020 Earnings Release and Conference Call”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-455386","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCipher Pharmaceuticals Schedules Q4 2020 Earnings Release and Conference Call - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cipher Pharmaceuticals Schedules Q4 2020 Earnings Release and Conference Call - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Canada NewsWire OAKVILLE, ON, March 10, 2021 \/CNW\/ –\u00a0Cipher Pharmaceuticals Inc. (TSX: CPH) (“Cipher” or “the Company“) today announced it will release its Q4 2020 financial results after the close on Thursday, March 18, 2021.\u00a0 The company will hold a conference call on Friday, March 19, 2021 to discuss the results. \u00a0 CONFERENCE CALL DETAILS DATE: March 19, 2021 TIME: 8:30 a.m. EDT DIAL-IN NUMBER: (416) 764-8688 or (888) 390-0546 CONFERENCE ID: 92839284 REPLAY DIAL-IN:\u00a0 (888) 390-0541 (playback 839284 #) Expires March 26, 2021 WEBCAST:\u00a0 https:\/\/produceredition.webcasts.com\/starthere.jsp?ei=1441329&tp_key=f472db2e8d About Cipher Pharmaceuticals Inc.Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages … Continue reading "Cipher Pharmaceuticals Schedules Q4 2020 Earnings Release and Conference Call"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-10T23:30:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=C2438&Transmission_Id=202103101826CANADANWWEB______C2438&DateId=20210310\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cipher Pharmaceuticals Schedules Q4 2020 Earnings Release and Conference Call\",\"datePublished\":\"2021-03-10T23:30:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\\\/\"},\"wordCount\":166,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/rt.prnewswire.com\\\/rt.gif?NewsItemId=C2438&Transmission_Id=202103101826CANADANWWEB______C2438&DateId=20210310\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\\\/\",\"name\":\"Cipher Pharmaceuticals Schedules Q4 2020 Earnings Release and Conference Call - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/rt.prnewswire.com\\\/rt.gif?NewsItemId=C2438&Transmission_Id=202103101826CANADANWWEB______C2438&DateId=20210310\",\"datePublished\":\"2021-03-10T23:30:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\\\/#primaryimage\",\"url\":\"https:\\\/\\\/rt.prnewswire.com\\\/rt.gif?NewsItemId=C2438&Transmission_Id=202103101826CANADANWWEB______C2438&DateId=20210310\",\"contentUrl\":\"https:\\\/\\\/rt.prnewswire.com\\\/rt.gif?NewsItemId=C2438&Transmission_Id=202103101826CANADANWWEB______C2438&DateId=20210310\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cipher Pharmaceuticals Schedules Q4 2020 Earnings Release and Conference Call\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cipher Pharmaceuticals Schedules Q4 2020 Earnings Release and Conference Call - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\/","og_locale":"en_US","og_type":"article","og_title":"Cipher Pharmaceuticals Schedules Q4 2020 Earnings Release and Conference Call - Market Newsdesk","og_description":"Canada NewsWire OAKVILLE, ON, March 10, 2021 \/CNW\/ –\u00a0Cipher Pharmaceuticals Inc. (TSX: CPH) (“Cipher” or “the Company“) today announced it will release its Q4 2020 financial results after the close on Thursday, March 18, 2021.\u00a0 The company will hold a conference call on Friday, March 19, 2021 to discuss the results. \u00a0 CONFERENCE CALL DETAILS DATE: March 19, 2021 TIME: 8:30 a.m. EDT DIAL-IN NUMBER: (416) 764-8688 or (888) 390-0546 CONFERENCE ID: 92839284 REPLAY DIAL-IN:\u00a0 (888) 390-0541 (playback 839284 #) Expires March 26, 2021 WEBCAST:\u00a0 https:\/\/produceredition.webcasts.com\/starthere.jsp?ei=1441329&tp_key=f472db2e8d About Cipher Pharmaceuticals Inc.Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages … Continue reading \"Cipher Pharmaceuticals Schedules Q4 2020 Earnings Release and Conference Call\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-10T23:30:17+00:00","og_image":[{"url":"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=C2438&Transmission_Id=202103101826CANADANWWEB______C2438&DateId=20210310","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cipher Pharmaceuticals Schedules Q4 2020 Earnings Release and Conference Call","datePublished":"2021-03-10T23:30:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\/"},"wordCount":166,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\/#primaryimage"},"thumbnailUrl":"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=C2438&Transmission_Id=202103101826CANADANWWEB______C2438&DateId=20210310","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\/","name":"Cipher Pharmaceuticals Schedules Q4 2020 Earnings Release and Conference Call - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\/#primaryimage"},"thumbnailUrl":"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=C2438&Transmission_Id=202103101826CANADANWWEB______C2438&DateId=20210310","datePublished":"2021-03-10T23:30:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\/#primaryimage","url":"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=C2438&Transmission_Id=202103101826CANADANWWEB______C2438&DateId=20210310","contentUrl":"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=C2438&Transmission_Id=202103101826CANADANWWEB______C2438&DateId=20210310"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cipher-pharmaceuticals-schedules-q4-2020-earnings-release-and-conference-call\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cipher Pharmaceuticals Schedules Q4 2020 Earnings Release and Conference Call"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/455386","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=455386"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/455386\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=455386"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=455386"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=455386"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}